Using ultrasound and blood tests to predict varices risk in cirrhosis
Part of Digestive system clinical trials.
This trial tests if a special ultrasound technique combined with liver stiffness and platelet count can predict which patients with cirrhosis have high-risk varices in the esophagus or stomach, potentially reducing the need for repeated endoscopy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 18 years old.
- You must have a diagnosis of cirrhosis (based on medical history, physical exam, lab tests, imaging, or liver biopsy).
- You must have had an upper endoscopy (gastroscopy) recently.
- You must not have had a past variceal bleed, TIPS procedure, or endoscopic treatment for varices.
- You must not have active liver cancer, a portal vein clot, or a removed spleen.
- You must not have used medications that affect platelets, liver function, or blood clotting in the past week, nor received a blood transfusion recently.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether using a special blood pressure measurement in the liver (called HVPG) can help doctors choose the best endoscopic treatment for people with cirrhosis who have had variceal bleeding. If you've had bleeding from varices, this study aims to make your follow-up care more personalized and effective.
This study tests whether ultrasound imaging can predict which patients with cirrhosis (scarring of the liver) are at higher risk of dangerous bleeding from enlarged veins in the esophagus. If successful, this could help doctors decide which patients need preventive treatment.
This trial compares two approaches to prevent future bleeding from enlarged veins in the esophagus (food pipe) in patients with liver cirrhosis who have already had one bleeding episode. You'll receive either an endoscopic procedure with medication or a minimally invasive vein procedure, to see which works better long-term.
This study tests whether treating enlarged veins in the esophagus or stomach (caused by cirrhosis) in a day-care unit is safe and works well. It may help people who need repeat endoscopic treatment for these varices.
This trial uses a simple ultrasound test (measuring liver and spleen stiffness) to predict if a patient with cirrhosis and advanced liver cancer has enlarged veins in the esophagus. The goal is to avoid unnecessary invasive procedures like endoscopy.
This trial tests a slightly smaller TIPS stent (underdilated) against the standard size to see which is better at preventing another variceal bleed in people with cirrhosis and liver scarring. It aims to find the safest way to lower pressure in the veins while reducing side effects.
Hear when a new Liver Cirrhosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.